Author
Listed:
- Sophia Maschalidi
(VIB Center for Inflammation Research
Ghent University)
- Parul Mehrotra
(VIB Center for Inflammation Research
Ghent University)
- Burcu N. Keçeli
(VIB Center for Inflammation Research
Ghent University)
- Hannah K. L. Cleene
(VIB Center for Inflammation Research
Ghent University)
- Kim Lecomte
(Ghent University
VIB Center for Inflammation Research)
- Renée Cruyssen
(Ghent University
Ghent University Hospital)
- Pauline Janssen
(Vrije Universiteit Brussel)
- Jonathan Pinney
(University of Virginia
University of Virginia)
- Geert Loo
(Ghent University
VIB Center for Inflammation Research)
- Dirk Elewaut
(Ghent University
Ghent University Hospital)
- Ann Massie
(Vrije Universiteit Brussel)
- Esther Hoste
(Ghent University
VIB Center for Inflammation Research)
- Kodi S. Ravichandran
(VIB Center for Inflammation Research
Ghent University
University of Virginia
University of Virginia)
Abstract
Chronic non-healing wounds are a major complication of diabetes, which affects 1 in 10 people worldwide. Dying cells in the wound perpetuate the inflammation and contribute to dysregulated tissue repair1–3. Here we reveal that the membrane transporter SLC7A11 acts as a molecular brake on efferocytosis, the process by which dying cells are removed, and that inhibiting SLC7A11 function can accelerate wound healing. Transcriptomics of efferocytic dendritic cells in mouse identified upregulation of several SLC7 gene family members. In further analyses, pharmacological inhibition of SLC7A11, or deletion or knockdown of Slc7a11 using small interfering RNA enhanced efferocytosis in dendritic cells. Slc7a11 was highly expressed in dendritic cells in skin, and single-cell RNA sequencing of inflamed skin showed that Slc7a11 was upregulated in innate immune cells. In a mouse model of excisional skin wounding, inhibition or loss of SLC7A11 expression accelerated healing dynamics and reduced the apoptotic cell load in the wound. Mechanistic studies revealed a link between SLC7A11, glucose homeostasis and diabetes. SLC7A11-deficient dendritic cells were dependent on aerobic glycolysis using glucose derived from glycogen stores for increased efferocytosis; also, transcriptomics of efferocytic SLC7A11-deficient dendritic cells identified increased expression of genes linked to gluconeogenesis and diabetes. Further, Slc7a11 expression was higher in the wounds of diabetes-prone db/db mice, and targeting SLC7A11 accelerated their wound healing. The faster healing was also linked to the release of the TGFβ family member GDF15 from efferocytic dendritic cells. In sum, SLC7A11 is a negative regulator of efferocytosis, and removing this brake improves wound healing, with important implications for wound management in diabetes.
Suggested Citation
Sophia Maschalidi & Parul Mehrotra & Burcu N. Keçeli & Hannah K. L. Cleene & Kim Lecomte & Renée Cruyssen & Pauline Janssen & Jonathan Pinney & Geert Loo & Dirk Elewaut & Ann Massie & Esther Hoste & K, 2022.
"Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes,"
Nature, Nature, vol. 606(7915), pages 776-784, June.
Handle:
RePEc:nat:nature:v:606:y:2022:i:7915:d:10.1038_s41586-022-04754-6
DOI: 10.1038/s41586-022-04754-6
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:606:y:2022:i:7915:d:10.1038_s41586-022-04754-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.